Silica for Paint: Matting, Anti-Settling and Rheology Functions Explained

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica Gel Desiccant: How It Works, Types, Capacity and How to Choose
  • Keywords: silica free flow agent
  • Published: 2026-11-20 01:40:52
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
7. Vallet-Regi M., Rámila A., Del Real R.P., Pérez-Pariente J. A new property of MCM-41: Drug delivery system. Chem. Mater. 2001;13:308-311. doi: 10.1021/cm0011559. [ DOI ] [ Google Scholar ]

Quartz Sand for Photovoltaic: High Purity Requirements for Solar Crucibles

What Is Sodium Silicate? Properties, Uses and Relationship to Silica
63. Radhakrishnan D., Patel V., Mohanan S., Ramadass K., Karakoti A., Vinu A. Folic acid functionalised mesoporous core-shell silica nanoparticles loaded with carboplatin for lung cancer therapy. Microporous Mesoporous Mater. 2023;360:112708. doi: 10.1016/j.micromeso.2023.112708. [ DOI ] [ Google Scholar ]
Silica Demand in 2026: Key Industries Driving Growth
Matting Agent Supplier: How to Choose the Right Silica Matting Agent Partner
100. Karaman D.Ṣ., Patrignani G., Rosqvist E., Smått J.-H., Orłowska A., Mustafa R., Preis M., Rosenholm J.M. Mesoporous silica nanoparticles facilitating the dissolution of poorly soluble drugs in orodispersible films. Eur. J. Pharm. Sci. 2018;122:152-159. doi: 10.1016/j.ejps.2018.06.027. [ DOI ] [ PubMed ] [ Google Scholar ]
Silicon Carbide vs Silica: Differences in Hardness, Structure and Uses
16. Izquierdo-Barba I., Martinez Á., Doadrio A.L., Pérez-Pariente J., Vallet-Regí M. Release evaluation of drugs from ordered three-dimensional silica structures. Eur. J. Pharm. Sci. 2005;26:365-373. doi: 10.1016/j.ejps.2005.06.009. [ DOI ] [ PubMed ] [ Google Scholar ]

Fumed Silica Alternatives: Cost-Effective Substitutes and How They Compare

What is silica (SiO₂)?

2500 mesh silica

What is the difference between fumed silica and precipitated silica?

food grade silica 49. Dwyer L.M., Michaelis V.K., O'Mahony M., Griffin R.G., Myerson A.S. Confined crystallization of fenofibrate in nanoporous silica. CrystEngComm. 2015;17:7922-7929. doi: 10.1039/C5CE01148E. [ DOI ] [ PMC free post ] [ PubMed ] [ Google Scholar ]

What drives silica raw material prices?

silicon dioxide covalent network One of the biggest challenges of tableting greatly potent APIs (antibiotics, hormones, cytostatic molecules) is to attain content uniformity [ 95, 96 ]. Since these molecules are used in small doses, it is demanding to attain a homogeneous powder mixture during mixing and to make sure this homogeneity until the end of tableting. Also, it is a hurdle to develop a reproducible method that ensures content uniformity for each production batch, since the specified dose must be made sure between batches, not just within one batch [ 95, 96 ]. A reliable alternative method is to use mesoporous silica as a carrier system rather than simple powder mixing, thus preventing the segregation and aggregation of the low-dose API during mixing and compression. In this case, the preloaded mesoporous carrier and the necessary excipients are mixed, and then the powder mixture can be compressed directly or after granulation. The drug loading can be controlled by the concentration of the drug solution used to fill the carrier systems, which affects the amount of the drug content in the concluding medicine [ 95, 96 ]. Based on this, nearly unlimitedly low doses can be formulated into tablets, even in a concentration of 0.01%, just by properly preparing the solution [ 96 ]. The technique is well-controllable and dependable, since each tablet has the same drug content and the desired content uniformity. Furthermore, the method can be used in both batch-based and continuous production [ 96 ]. This may be a promising finding because there is evidence that it is challenging to move from batch-based to continuous manufacturing while maintaining the desired drug content and content uniformity [ 94 ]. But it should be noted that in this study, no nanocarrier system was used [ 94 ], so utilizing MSN formulations could make an enormous improvement in developing continuous tablet manufacturing [ 96 ]. A study shown that MSN carriers can also be used in orodispersible films to enhance the dissolution of poorly water-soluble drugs [ 100 ]. Based on in vitro drug release studies, more than 90% of prednisolone was released within 2 min when the loaded MSN was incorporated into the formulation. This means a much faster, immediate release in comparison with formulations containing the free form of the drug. In addition, precise dosing can be accomplished utilizing nanocarriers for personalized medication; furthermore, enabling the production of low-dose preparations without content uniformity problems [ 100 ].

Cite this article: Silica Raw Materials News. "Silica as an Anti-Caking Agent: How It Works and Where It Is Used ." Published 2026-11-20 01:40:52. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.